The Role of Complement in Stroke Therapy

被引：23

作者：

Komotar, Ricardo J. ^{[1
]}

Kim, Grace H. ^{[1
]}

Often, Marc L. ^{[1
]}

Hassid, Benjamin ^{[1
]}

Mocco, J. ^{[1
]}

Sughrue, Michael E. ^{[1
]}

Starke, Robert M. ^{[1
]}

Mack, William J. ^{[1
]}

Ducruet, Andrew F. ^{[1
]}

Merkow, Maxwell B. ^{[1
]}

Garrett, Matthew C. ^{[1
]}

Connolly, E. Sander ^{[1
]}

机构：

[1] Columbia Univ, Dept Neurol Surg, New York, NY 10027 USA

来源：

CURRENT TOPICS IN COMPLEMENT II | 2008年 / 632卷

关键词：

D O I：

10.1007/978-0-387-78952-1_2

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Cerebral ischemia and reperfusion initiate an inflammatory process which results in secondary neuronal damage. Immunomodulatory agents represent a promising means of salavaging viable tissue following stroke. The complement cascade is a potent mediator of inflammation which is activated following cerebral ischemia. Complement is deposited on apoptotic neurons which likely leads to injury in adjacent viable cells. Studies suggest that blocking the complement cascade during the early phases of infarct evolution may result in decreased penumbral tissue infarction and limit the extent of brain injury. Additionally, other elements of the complement cascade may play a critical role in cell survival. In this paper, we review the role of the complement cascade in neuronal damage following ischemic injury and emphasize possible therapeutic targets.

引用

页码：23 / 33

页数：11

共 83 条

[51]

Morgan BP, 1997, IMMUNOPHARMACOLOGY, V38, P43

[52] Expression of complement in the brain: Role in health and disease [J].

Morgan, BP ;

Gasque, P .

IMMUNOLOGY TODAY, 1996, 17 (10) :461-466

[53] Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3 [J].

Mukherjee, P ;

Pasinetti, GM .

JOURNAL OF NEUROCHEMISTRY, 2001, 77 (01) :43-49

[54] The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease [J].

Mukherjee, P ;

Pasinetti, GM .

JOURNAL OF NEUROIMMUNOLOGY, 2000, 105 (02) :124-130

[55]

Osaka H, 1999, J CELL BIOCHEM, V73, P303, DOI 10.1002/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.3.CO

[56]

2-U

[57] Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions [J].

Pasinetti, GM ;

Tocco, G ;

Sakhi, S ;

Musleh, WD ;

DeSimoni, MG ;

Mascarucci, P ;

Schreiber, S ;

Baudry, M ;

Finch, CE .

NEUROBIOLOGY OF DISEASE, 1996, 3 (03) :197-204

[58] Complement: a novel factor in basal and ischemia-induced neurogenesis [J].

Rahpeymai, Y ;

Hietala, MA ;

Wilhelmsson, U ;

Fotheringham, A ;

Davies, I ;

Nilsson, AK ;

Zwirner, J ;

Wetsel, RA ;

Gerard, C ;

Pekny, M ;

Pekna, M .

EMBO JOURNAL, 2006, 25 (06) :1364-1374

[59] Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice [J].

Rancan, M ;

Morganti-Kossmann, MC ;

Barnum, TR ;

Saft, T ;

Schmidt, TOI ;

Ertel, WG ;

Stahel, PF .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2003, 23 (09) :1070-1074

[60] Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells [J].

Ratajczak, MZ ;

Reca, R ;

Wysoczynski, M ;

Kucia, M ;

Baran, JT ;

Allendorf, DJ ;

Ratajczak, J ;

Ross, GD .

LEUKEMIA, 2004, 18 (09) :1482-1490

← 1 2 3 4 5 6 7 8 9 →